IP Library Granted Patent US 7,906,629
Granted Patent B2
US 7,906,629 · App. 11/669,200 · Granted Mar 15, 2011

Protease inhibitor conjugates and antibodies useful in immunoassay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,906,629
App. No.
11/669,200
Granted
Mar 15, 2011
Kind
B2
Abstract

Activated haptens useful for generating immunogens to HIV protease inhibitors, immunogens useful for producing antibodies to HIV protease inhibitors, and antibodies and labeled conjugates useful in immunoassays for the HIV protease inhibitor saquinavir. The novel haptens feature an activated functionality at the central, non-terminal hydroxyl group. Also described are monoclonal antibodies specific for saquinavir having less than 10% cross-reactivity with lopinavir, nelfinavir, amprenavir, ritonavir, and indinavir, and a murine hybridoma producing said antibodies.

Claims (25)

1. A compound having the structure

wherein

Y is O, S or NH,

m is 1,

L is a linker comprising from 3 to 40 carbon atoms arranged in a straight chain or a branched chain, saturated or unsaturated, and containing up to two ring structures and 0-20 heteroatoms, with the proviso that not more than two heteroatoms may be linked in sequence and the first atom in L adjacent to C═Y is N, and

A is an activated functionality selected from the group consisting of active esters, isocyanates, isothiocyanates, thiols, imidoesters, anhydrides, maleimides, thiolactones, diazonium groups and aldehydes.

2. The compound of claim 1 wherein Y is O.

3. The compound of claim 1 wherein Y is S.

4. The compound of claim 1 wherein Y is NH.

5. A compound having the structure

wherein

Y is O, S, or NH,

m is 1,

L is a linker comprising 3 to 40 carbon atoms arranged in a straight chain or a branched chain, saturated or unsaturated, and further comprising up to two ring structures and 0-20 heteroatoms, with the proviso that not more than two heteroatoms are linked in sequence and the first atom in L adjacent to C═Y is N,

Z is a moiety selected from the group consisting of —CONH—, —NHCO—, —NHCONH—, —NHCSNH—, —OCONH—, —NHOCO—, —S—, —NH(C═NH)—, —N═N—, —NH—, and

P is selected from the group consisting of an aminated dextran, bovine serum albumin, keyhole limpet hemocyanin, Limulus polyphemus hemocyanin, and bovine thyroglobulin, and

n is a number from 1 to 50 per 50 kilodaltons molecular weight of P.

6. A compound having the structure

wherein

Y is O, S, or NH,

m is 1,

L is a linker comprising 3 to 40 carbon atoms arranged in a straight chain or a branched chain, saturated or unsaturated, and further comprising up to two ring structures and 0-20 heteroatoms, with the proviso that not more than two heteroatoms are linked in sequence and the first atom in L adjacent to C═Y is N,

Z is a moiety selected from the group consisting of —CONH—, —NHCO—, —NHCONH—, —NHCSNH—, —OCONH—, —NHOCO—, —S—, —NH(C═NH)—, —N═N—, —NH—, and

Q is biotin, and

n is a number from 1 to 50 per 50 kilodaltons molecular weight of Q.